Access cutting-edge systemic lupus erythematosus treatment through this clinical trial at a research site in Flagstaff. Study-provided care at no cost to qualified participants.
Access systemic lupus erythematosus specialists in Flagstaff at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic lupus erythematosus treatment provided free
Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how safe and effective upadacitinib is in treating adult participants with moderately to severely active SLE. Adverse events and change in the disease activity will be assessed. Upadacitinib is an approved drug for rheumatoid arthritis, psoriatic arthritis, and axial spondylarthritis and is being developed for the treatment of SLE. This study is "double
Sponsor: AbbVie
Check if you qualify for this systemic lupus erythematosus clinical trial in Flagstaff, AZ
If you're searching for systemic lupus erythematosus treatment options in Flagstaff, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Flagstaff research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic lupus erythematosus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.